Proposal | Vote Required | Effect of Broker Non-Votes, Withhold Votes and Abstentions | |||||||||||||||
1. | Election of Directors | The three nominees who receive the most votes will be elected. | Broker non-votes and withhold votes have no effect. | ||||||||||||||
2. | Advisory vote to approve executive compensation (Say on Pay) | Affirmative vote of the holders of a majority of the shares of common stock represented and entitled to vote at the Meeting. | Broker non-votes and abstentions have the same effect as a vote against the proposal. | ||||||||||||||
3. | Approval of the 2021 Equity Incentive Plan | Affirmative vote of the holders of a majority of the shares of common stock represented and entitled to vote at the Meeting. | Broker non-votes and abstentions have the same effect as a vote against the proposal. | ||||||||||||||
4. | Selection of Auditor | Affirmative vote of the holders of a majority of the shares of common stock represented and entitled to vote at the Meeting. | Abstentions have the same effect as a vote against the proposal. |
Name | Benefit | Termination w/o Cause or Material Change | Change in Control | After Change in Control – Material Change or w/o Cause1 | Voluntary Termination | Death | Disability | ||||||||||||||||||||||||||||||||||
Larry A. Mizel | Severance Pay | $ | 3,000,000 | 2 | $ | 3,000,000 | 2 | $ | 3,000,000 | 2 | $ | 3,000,000 | 2 | ||||||||||||||||||||||||||||
Ann. Incentive Comp. | $ | 18,000,000 | 3 | $ | 18,000,000 | 3 | $ | 18,000,000 | 3 | $ | 18,000,000 | 3 | |||||||||||||||||||||||||||||
Stock/Option Vesting | $ | 47,966,467 | 4 | $ | 47,966,467 | 4 | $ | 47,966,467 | 11 | $ | 47,966,467 | 11 | |||||||||||||||||||||||||||||
Health Care Benefits | $ | 222,032 | 5 | $ | 222,032 | 5 | $ | 222,032 | 5 | $ | 90,704 | 5 | $ | 222,032 | 5 | ||||||||||||||||||||||||||
David D. Mandarich | Severance Pay | $ | 2,490,000 | 2 | $ | 2,490,000 | 2 | $ | 2,490,000 | 2 | $ | 2,490,000 | 2 | ||||||||||||||||||||||||||||
Ann. Incentive Comp. | $ | 12,000,000 | 3 | $ | 12,000,000 | 3 | $ | 12,000,000 | 3 | $ | 12,000,000 | 3 | |||||||||||||||||||||||||||||
Stock/Option Vesting | $ | 47,966,467 | 4 | $ | 47,966,467 | 4 | $ | 47,966,467 | 11 | $ | 47,966,467 | 11 | |||||||||||||||||||||||||||||
Health Care Benefits | $ | 297,968 | 5 | $ | 297,968 | 5 | $ | 297,968 | 5 | $ | 90,704 | 5 | $ | 297,968 | 5 | ||||||||||||||||||||||||||
Robert N. Martin | Severance Pay | $ | 1,600,000 | 6 | |||||||||||||||||||||||||||||||||||||
Bonus Payment | $ | 800,000 | 7 | ||||||||||||||||||||||||||||||||||||||
Stock/Option Vesting | $ | 9,812,875 | 8 | $ | 831,595 | 9 | $ | 8,981,280 | 13 | $ | 9,812,875 | 11 | $ | 9,812,875 | 11 | ||||||||||||||||||||||||||
Health Care Benefits | $ | 28,389 | 10 | ||||||||||||||||||||||||||||||||||||||
Rebecca B. Givens | Severance Pay | $ | 900,000 | 6 | |||||||||||||||||||||||||||||||||||||
Bonus Payment | $ | 400,000 | 7 | ||||||||||||||||||||||||||||||||||||||
Stock/Option Vesting | $ | 249,901 | 8 | $ | 249,901 | 9 | |||||||||||||||||||||||||||||||||||
Health Care Benefits | $ | 148 | 10 | ||||||||||||||||||||||||||||||||||||||
Michael Touff | Severance Pay | $ | 240,000 | 12 | $ | 240,000 | 12 | ||||||||||||||||||||||||||||||||||
Stock/Option Vesting | $ | 190,852 | 8 | $ | 190,852 | 9 | $ | 190,852 | 11 | $ | 190,852 | 11 |
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